US Patent

US9872906 — Ceftolozane antibiotic compositions

Formulation · Assigned to Merck Sharp and Dohme LLC · Expires 2034-03-14 · 8y remaining

Vulnerability score 42/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects pharmaceutical compositions of ceftolozane, including those with tazobactam, and methods for preparing and using these compositions.

USPTO Abstract

This disclosure provides pharmaceutical compositions comprising ceftolozane, pharmaceutical compositions comprising ceftolozane and tazobactam, methods of preparing those compositions, and related methods and uses of these compositions.

Drugs covered by this patent

Patent Metadata

Patent number: US9872906
Jurisdiction: US
Classification: Formulation
Expires: 2034-03-14
Drug substance claim: No
Drug product claim: Yes
Assignee: Merck Sharp and Dohme LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.